glp 1 and strength training Rethinking Exercise on GLP-1 Medications: Why is Key 30-Day GLP-1 Strength Training Program
Description
Sodium-Glucose Cotransporter-2 Inhibition for the Reduction of Cardiovascular Events in High-Risk Patients with Diabetes Mellitus

JANUVIA WORKs in 2 ways with a glucose-dependent mechanism of actION increasing insulin production and reducing hepatic glucose production DPP-4 Inhibition Oral glucose stimulates release of incretins (GLP-1 and GIP) DPP-4 rapidly degrades incretins JANUVIA inhibits DPP-4 to increase active incretins

[DOI] [PMC free article] [PubMed] [Google Scholar] 134.Jastreboff A.M., Aronne L.J., Ahmad N.N., Wharton S., Connery L., Alves B., Kiyosue A., Zhang S., Liu B., Bunck M.C., et al
:max_bytes(150000):strip_icc()/Health-GettyImages-2253438005-Exported-0b4e8bc256fc464297ff339a24dd8d60.jpg)
But their downsides are well-documented: high monthly costs, potential side effects such as nausea or gastrointestinal discomfort, and the need for injections

Common gastrointestinal side effects are the most frequently reported adverse reactions, particularly during treatment initiation and dose escalation: Nausea (affecting 2040% of patients initially) Vomiting and diarrhoea Constipation Abdominal discomfort or bloating These symptoms typically diminish over several weeks as tolerance develops

Can I use it long-term
